| DSU: About us |
   
|
|
   
|
The
Analytical Division of the Drug Studies Unit (DSU) applies Good Laboratory
Practice (GLP) standards to meet the drug assay development requirements
necessary in submissions to the Food and Drug Administration. The DSU was
established in 1977 by the late Dr. Sid Riegelman, Dr. Leslie Benet
(former Chairman of the Department of Biopharmaceutical Sciences) and Dr.
Roger Williams (USP). With over 20 years experience in drug and metabolite
analysis of biological fluids, method development and validation, the Drug
Studies Unit serves as an educational, scientific and financial resource
of the Department of Biopharmaceutical Sciences in the School
of Pharmacy at the University of California, San Francisco. |
|
| The
Analytical Division is committed to the development of analytical methods
to detect and quantify drug substances in biological fluids at the
concentrations necessary for bioavailability, pharmacokinetic, drug
metabolism and drug monitoring studies. In addition, the Division performs
routine analyses of biological specimens to support pharmacokinetic and
bioavailability studies as part of preclinical and clinical investigations
for the development of new drugs. Our methods are validated according to
rigorous and tested standard operating procedures. Quality is maintained
during sample analysis through frequent monitoring to assure compliance
with quality control specifications. |
|
|
